TY - JOUR
T1 - Sex Disparity in Cause-Specific and All-Cause Mortality Among Incident Dialysis Patients
AU - Lim, Wai H.
AU - Chen, Jenny H.C.
AU - Minas, Kimberley
AU - Johnson, David W.
AU - Ladhani, Maleeka
AU - Ooi, Esther
AU - Boudville, Neil
AU - Hawley, Carmel
AU - Viecelli, Andrea K.
AU - Roberts, Matthew
AU - Wyburn, Kate
AU - Walker, Rachael
AU - Borlace, Monique
AU - Pilmore, Helen
AU - Davies, Christopher E.
AU - Lok, Charmaine E.
AU - Teixeira-Pinto, Armando
AU - Wong, Germaine
N1 - Funding Information:
Wai H. Lim, PhD, Jenny H.C. Chen, FRACP, Kimberley Minas, MBBS, David W. Johnson, PhD, Maleeka Ladhani, PhD, Esther Ooi, PhD, Neil Boudville, FRACP, Carmel Hawley, FRACP, Andrea K. Viecelli, PhD, Matthew Roberts, PhD, Kate Wyburn, PhD, Rachael Walker, MN, Monique Borlace, MN, Helen Pilmore, FRACP, Christopher E. Davies, PhD, Charmaine E. Lok, MD, FRCP, Armando Teixeira-Pinto, PhD, and Germaine Wong, PhD. Research idea and study design: WHL, JHCC, GW; data interpretation: WHL, EO, GW, KM; statistical analysis: WHL, EO, GW, AT-P; data interpretation; all authors. Each author contributed important intellectual content during manuscript drafting or revision and agrees to be personally accountable for the individual's own contributions and to ensure that questions pertaining to the accuracy or integrity of any portion of the work, even one in which the author was not directly involved, are appropriately investigated and resolved, including with documentation in the literature if appropriate. This work received no direct financial support. Dr Johnson is supported by a National Health and Medical Research Council (NHMRC) Practitioner Fellowship. Dr Viecelli is supported by a Queensland Advancing Clinical Research Fellowship and an NHMRC Emerging Leader Grant (1196033). Dr Wong is supported by an NHMRC Career Development Fellowship. Dr Ooi is supported by a Heart Foundation Future Leader Fellowship (award ID: 102538). Dr Lim has received educational grants from Astellas. The other authors declare that they have no relevant financial interests. The authors would like to gratefully acknowledge the substantial contributions of the entire Australian and New Zealand nephrology community (physicians, surgeons, database managers, nurses, renal operators, and patients) that provide information to, and maintain, the ANZDATA database. The data reported here have been supplied by the ANZDATA registry. The interpretation and reporting of these data are the authors’ responsibility and in no way should be seen as official policy or interpretation of the ANZDATA registry. Aspects of this work were presented in abstract form at the 55th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), held November 28 to December 2, 2020. Received February 1, 2022. Evaluated by 3 external peer reviewers and a statistician, with editorial input from an Acting Editor-in-Chief (Editorial Board Member Juan-Jesus Carrero, PhD). Accepted in revised form July 14, 2022. The involvement of an Acting Editor-in-Chief to handle the peer-review and decision-making processes was to comply with AJKD's procedures for potential conflicts of interest for editors, described in the Information for Authors & Journal Policies.
Funding Information:
Dr Lim has received educational grants from Astellas. The other authors declare that they have no relevant financial interests.
Funding Information:
This work received no direct financial support. Dr Johnson is supported by a National Health and Medical Research Council (NHMRC) Practitioner Fellowship. Dr Viecelli is supported by a Queensland Advancing Clinical Research Fellowship and an NHMRC Emerging Leader Grant (1196033). Dr Wong is supported by an NHMRC Career Development Fellowship. Dr Ooi is supported by a Heart Foundation Future Leader Fellowship (award ID: 102538).
Publisher Copyright:
© 2022 National Kidney Foundation, Inc.
PY - 2023/2
Y1 - 2023/2
N2 - Rationale & Objective: Early mortality rates of female patients receiving dialysis have been, at times, observed to be higher than rates among male patients. The differences in cause-specific mortality between male and female incident dialysis patients with kidney failure are not well understood and were the focus of this study. Study Design: Retrospective cohort study. Setting & Participants: Incident patients who had initiated dialysis in Australia and New Zealand in 1998-2018. Exposure: Sex. Outcomes: Cause-specific and all-cause mortality while receiving dialysis, censored for kidney transplant. Analytical Approach: Adjusted cause-specific proportional hazards models, focusing on the first 5 years following initiation of dialysis. Results: Among 53,414 patients (20,876 [39%] female) followed for a median period of 2.8 (IQR, 1.3-5.2) years, 27,137 (51%) died, with the predominant cause of death attributed to cardiovascular disease (18%), followed by dialysis withdrawal (16%). Compared with male patients, female patients were more likely to die in the first 5 years after dialysis initiation (adjusted hazard ratio [AHR], 1.08 [95% CI, 1.05-1.11]). Even though female patients experienced a lower risk of cardiovascular disease–related mortality (AHR, 0.93 [95% CI, 0.89-0.98]) than male patients, they experienced a greater risk of infection-related (AHR, 1.20 [95% CI, 1.10-1.32]) and dialysis withdrawal–related (AHR, 1.19 [95% CI, 1.13-1.26]) mortality. Limitations: Possibility of residual and unmeasured confounders. Conclusions: Compared with male patients, female patients had a higher risk of all-cause mortality in the first 5 years after dialysis initiation, a difference driven by higher rates of mortality from infections and dialysis withdrawals. These findings may inform the study of sex differences in mortality in other geographic settings.
AB - Rationale & Objective: Early mortality rates of female patients receiving dialysis have been, at times, observed to be higher than rates among male patients. The differences in cause-specific mortality between male and female incident dialysis patients with kidney failure are not well understood and were the focus of this study. Study Design: Retrospective cohort study. Setting & Participants: Incident patients who had initiated dialysis in Australia and New Zealand in 1998-2018. Exposure: Sex. Outcomes: Cause-specific and all-cause mortality while receiving dialysis, censored for kidney transplant. Analytical Approach: Adjusted cause-specific proportional hazards models, focusing on the first 5 years following initiation of dialysis. Results: Among 53,414 patients (20,876 [39%] female) followed for a median period of 2.8 (IQR, 1.3-5.2) years, 27,137 (51%) died, with the predominant cause of death attributed to cardiovascular disease (18%), followed by dialysis withdrawal (16%). Compared with male patients, female patients were more likely to die in the first 5 years after dialysis initiation (adjusted hazard ratio [AHR], 1.08 [95% CI, 1.05-1.11]). Even though female patients experienced a lower risk of cardiovascular disease–related mortality (AHR, 0.93 [95% CI, 0.89-0.98]) than male patients, they experienced a greater risk of infection-related (AHR, 1.20 [95% CI, 1.10-1.32]) and dialysis withdrawal–related (AHR, 1.19 [95% CI, 1.13-1.26]) mortality. Limitations: Possibility of residual and unmeasured confounders. Conclusions: Compared with male patients, female patients had a higher risk of all-cause mortality in the first 5 years after dialysis initiation, a difference driven by higher rates of mortality from infections and dialysis withdrawals. These findings may inform the study of sex differences in mortality in other geographic settings.
KW - cardiovascular mortality
KW - cause of death
KW - dialysis
KW - dialysis withdrawal
KW - end-stage renal disease (ESRD)
KW - health care disparities
KW - infection
KW - kidney failure
KW - mortality
KW - Sex
KW - sex disparities
UR - http://www.scopus.com/inward/record.url?scp=85146064795&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2022.07.007
DO - 10.1053/j.ajkd.2022.07.007
M3 - Article
C2 - 36029966
AN - SCOPUS:85146064795
SN - 0272-6386
VL - 81
SP - 156-167.e1
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 2
ER -